All Stories

  1. Current and future developments in the treatment of virus-induced hypercytokinemia
  2. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria
  3. Nucleic acid-based drugs against emerging zoonotic viruses
  4. Frontiers in nucleic acid-based drug research and development
  5. Experimental antiviral drugs against pandemic influenza
  6. Confronting the emerging threats from zoonotic and mosquito-borne viruses
  7. The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy
  8. Vaccines and therapeutics for the encephalitic alphaviruses
  9. Nucleic acid-based drugs against the highly pathogenic H5N1 avian influenza virus infection
  10. Recent Patents on Development of Nucleic Acid-Based Antiviral Drugs against Seasonal and Pandemic Influenza Virus Infections
  11. Prophylactic, therapeutic and immune enhancement effect of liposome-encapsulated PolyICLC on highly pathogenic H5N1 influenza infection
  12. Aerosol and nasal delivery of vaccines and antiviral drugs against seasonal and pandemic influenza
  13. Recent Patents in Antiviral siRNAs
  14. Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza
  15. Protection against Seasonal and Avian Influenza Virus Infections Using Nucleic Acid-Based Antiviral Agents
  16. Broad-Spectrum Antiviral Activity of Nucleic Acid-Based Antiviral Agents Against Avian and Seasonal Influenza Viruses
  17. 299 Cytokine response to liposome-encapsulated Poly ICLC prophylaxis of influenza A virus infection
  18. Broad-Spectrum Drugs Against Viral Agents
  19. Editorial [Hot Topic:Avian and Pandemic Influenza Cytokine Storm, Inflammation,Tissue and Therapeutic Opportunities (Guest Editor: Jonathan P. Wong)]
  20. Feasibility and Prospects for Anti-Inflammatory Antibodies in the Treatment and Disease Management of Influenza
  21. Therapeutic efficacy of aerosolized liposome-encapsulated nubiotic against pulmonary Pseudomonas aeruginosa infection
  22. Recent Patents on Development of Nucleic Acid-based Antiviral Drugs against Seasonal and Pandemic Influenza Virus Infections
  23. Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses
  24. Protective role of DNA vaccination and passive immunization against the 1918 pandemic influenza virus
  25. Recent Developments in Delivery of Nucleic Acid-Based Antiviral Agents
  26. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery
  27. Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs
  28. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses
  29. Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection
  30. A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling
  31. Determination of surface free energy of interactive dry powder liposome formulations using capillary penetration technique
  32. Immunoprophylactic strategies against respiratory influenza virus infection
  33. DNA vaccination against respiratory influenza virus infection
  34. Pharmacokinetics Study of a Novel Chimeric Single-Chain Variable Fragment Antibody Against Western Equine Encephalitis Virus
  35. Effects of Liposome-Encapsulated Ciprofloxacin on Phagocytosis, Nitric Oxide and Intracellular Killing ofStaphylococcus Aureusby Murine Macrophages
  36. Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC
  37. Rapid immunofiltration assay of Newcastle disease virus using a silicon sensor
  38. Sensitive fluorogenic enzyme immunoassay on nitrocellulose membranes for quantitation of virus
  39. Current Status on Development of Nucleic Acid-Based Antiviral Drugs Against Influenza Virus Infection